scholarly journals The Role of Tissue and Liquid Biopsy in the Clinical Management of Adult Lung Cancer Patients in King Abdul-Aziz Medical City in Riyadh, Saudi Arabia

Cureus ◽  
2022 ◽  
Author(s):  
Lafi Alanazi ◽  
Ryan N Alqahtani ◽  
Nazish Masud ◽  
Meshal M Zuraie ◽  
Abdulrahman A Bin Afif ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Saudi Arabia ◽  
Cancer Patients ◽  
Liquid Biopsy ◽  
Clinical Management ◽  
Lung Cancer Patients ◽  
Adult Lung ◽  
Medical City

scholarly journals The potential role of SPECT/CT in the clinical management of COVID-19 lung cancer patients undergoing radiotherapy

2021 ◽  
Author(s):  
Paolo Borghetti ◽  
Cristian Toraci ◽  
Jessica Imbrescia ◽  
Giulia Volpi ◽  
Silvia Lucchini ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cancer Patients ◽  
Clinical Management ◽  
Potential Role ◽  
Lung Cancer Patients

scholarly journals The Role of the Liquid Biopsy in Decision-Making for Patients with Non-Small Cell Lung Cancer

2020 ◽  
Vol 9 (11) ◽  
pp. 3674
Author(s):  
D. Akhoundova ◽  
J. Mosquera Martinez ◽  
L. E. Musmann ◽  
C. Britschgi ◽  
C. Rütsche ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Clinical Practice ◽  
Cancer Patients ◽  
Liquid Biopsy ◽  
Clinical Management ◽  
Circulating Tumor Dna ◽  
Precision Oncology ◽  
Liquid Biopsies ◽  
Lung Cancer Patients ◽  
Molecular Alterations

Liquid biopsy is a rapidly emerging tool of precision oncology enabling minimally invasive molecular diagnostics and longitudinal monitoring of treatment response. For the clinical management of advanced stage lung cancer patients, detection and quantification of circulating tumor DNA (ctDNA) is now widely adopted into clinical practice. Still, interpretation of results and validation of ctDNA-based treatment decisions remain challenging. We report here our experience implementing liquid biopsies into the clinical management of lung cancer. We discuss advantages and limitations of distinct ctDNA assay techniques and highlight our approach to the analysis of recurrent molecular alterations found in lung cancer. Moreover, we report three exemplary clinical cases illustrating the complexity of interpreting liquid biopsy results in clinical practice. These cases underscore the potential and current limitations of liquid biopsy, focusing on the difficulty of interpreting discordant findings. In our view, despite all current limitations, the analysis of ctDNA in lung cancer patients is an essential and highly versatile complementary diagnostic tool for the clinical management of lung cancer patients in the era of precision oncology.

scholarly journals P3.01-037 The Role of HIF3A Polymorphism in Lung Cancer Patients

2017 ◽  
Vol 12 (1) ◽  
pp. S1142-S1143
Author(s):  
Andika Putra ◽  
Keiko Hiyama ◽  
Keiji Tanimoto
Keyword(s):  
Lung Cancer ◽  
Cancer Patients ◽  
Lung Cancer Patients

The role of Coronary Artery Calcification Score in lung cancer patients

2021 ◽  
pp. 110140
Author(s):  
Valerio Nardone ◽  
Alfonso Reginelli ◽  
Giuseppina De Marco ◽  
Teresa Di Pietro ◽  
Roberta Grassi ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Coronary Artery ◽  
Cancer Patients ◽  
Coronary Artery Calcification ◽  
Coronary Artery Calcification Score ◽  
Lung Cancer Patients ◽  
Calcification Score
Sign in / Sign up

Export Citation Format

Share Document